CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Grant or award CAO/SVP, Finance acquired 22,940 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 81,823 shares at $2.65 ($216,831)
- 8-K Event Other events
- 8-K Event Executive or director change · Other events
- 4 Option exercise Director acquired 88,000 shares (option exercise)
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market sale Chief Executive Officer sold 90,000 shares at $3.74 ($336,600)
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
Page 16 of 45 · 895 filings